We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Neovasc Inc | NASDAQ:NVCN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 30.03 | 27.70 | 30.00 | 0 | 01:00:00 |
NASDAQ, TSX: NVCN
VANCOUVER, Aug. 2, 2018 /CNW/ - Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ:NVCN)(TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, today announced that it will report financial results for the quarter and six months ended June 30, 2018 and host a conference call and webcast at 4:30pm Eastern Time on Wednesday, August 8, 2018.
Conference Call & Webcast |
|
Wednesday, August 8th @ 4:30pm Eastern Time |
|
Domestic: |
888-254-3590 |
International: |
323-994-2093 |
Passcode: |
9226007 |
Webcast: |
http://public.viavid.com/index.php?id=130206 |
Replays available through August 22nd: |
|
Domestic: |
844-512-2921 |
International: |
412-317-6671 |
Conference ID: |
9226007 |
About Neovasc Inc.
Neovasc is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include the Neovasc Reducer™ (the "Reducer"), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara™ (the "Tiara"), for the transcatheter treatment of mitral valve disease, which is currently under clinical investigation in the United States , Canada and Europe . For more information, visit: www.neovasc.com.
SOURCE Neovasc Inc.
Copyright 2018 Canada NewsWire
1 Year Neovasc Chart |
1 Month Neovasc Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions